C-MET overexpression is common in HNSCC patients, and overactivation of MET signaling contributes to resistance to anti-EGFR therapy.108,502 Most c-MET inhibitors are multitarget inhibitors that mainly inhibit the function of c-MET. Here, MET is linked to head and neck squamous cell carcinoma.